ESEiko Shimada

Eiko Shimada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eiko Shimada has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Yoshihisa Watanabe

    From the Research and Development Department, Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan; and the National Blood Center, Thai Red Cross Society, Henri Dunant Road, Pathumwan, Bangkok, Thailand

    4 shared publications
  • Takeo Juji

    From the Research and Development Department, Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan; and the National Blood Center, Thai Red Cross Society, Henri Dunant Road, Pathumwan, Bangkok, Thailand

    3 shared publications
  • Kazumi Isa

    The Japanese Red Cross, Blood Service Headquarters, Central Blood Institute

    2 shared publications
  • Kenji Tadokoro

    From the Research and Development Department, Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan; and the National Blood Center, Thai Red Cross Society, Henri Dunant Road, Pathumwan, Bangkok, Thailand

    2 shared publications
  • Toshio Mazda

    From the Research and Development Department, Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan; and the National Blood Center, Thai Red Cross Society, Henri Dunant Road, Pathumwan, Bangkok, Thailand

    2 shared publications
  • Emi Matsuo

    1 shared publication

Latest Publications

  • Detection of Hpdel among Thais, a deleted allele of the haptoglobin gene that causes congenital haptoglobin deficiency

    by Eiko Shimada, Miki Odagiri, Kriangsak Chaiwong, Yoshihisa Watanabe, Masako Anazawa, Toshio Mazda, Hitoshi Okazaki, Takeo Juji, Rachanee O'CHaroen, Kenji Tadokoro

    BACKGROUND: Congenital haptoglobin deficiency is a risk factor for anaphylactic nonhemolytic transfusion reactions in Japan. The deleted allele of the haptoglobin gene, Hpdel, which causes congenital haptoglobin deficiency, has also been observed in other Northeast Asian populations, such as Korean and Chinese persons. It has not been reported in several African and European‐African populations, however, or investigated in other countries.STUDY DESIGN AND METHODS: To investigate the distribution of congenital haptoglobin deficiency in Southeast Asian countries, blood samples collected from 200 randomly selected healthy Thai volunteers were analyzed for serum haptoglobin and the haptoglobin gene. Plasma haptoglobin concentration was measured to identify haptoglobin deficiency. Haptoglobin phenotyping was performed with sodium dodecyl sulfate–polyacrylamide gel electrophoresis followed by Western blotting. The presence of the Hpdel allele was determined with genomic DNA by an Hpdel‐specific polymerase chain reaction (PCR) method.RESULTS: There were no haptoglobin‐deficient subjects detected among the 200 Thais. Their haptoglobin phenotypes were as follows: Hp 1‐1 in 10, Hp 2‐1 in 81, and Hp 2‐2 in 109. Six individuals heterozygous for Hpdel were detected. The frequency of the Hpdel allele was calculated to be 0.015. The prevalence of haptoglobin deficiency caused by Hpdel homozygosity was estimated to be approximately 1 in 4000.CONCLUSION: Congenital haptoglobin deficiency caused by Hpdel homozygosity is presumed to be present in Thailand as a risk factor for anaphylactic transfusion reactions with a frequency similar to that in Japan. The causative deleted allele of the haptoglobin gene, Hpdel, is distributed among Southeast Asian populations as well as among Northeast Asian populations.


  • A SIMPLE ELISA FOR THE DETECTION OF HAPTOGLOBIN DEFICIENCY

    by Eiko Shimada, Kazumi Isa, Ikiko Maeda, Hiromi Kamada, Shiho Hashimoto, Yoshihisa Watanabe, Toshio Mazda, Hitoshi Okazaki, Takeo Juji

    背景: ハプトグロビン (Hp) 欠損は, 国内における輸血アナフィラキシー発生の一因と考えられている.目的: サンドイッチELISAを用いた簡便なHp欠損の検出法を検討する.方法: 被検患者血清コントロール血清, スタンダードHpを, ウサギ抗ヒトHpポリクローナル抗体を固相化したマイクロプレートに添加して, 10分間反応させ, プレートを洗浄後, 結合したHpをHRP標識抗ヒトHpヤギ血清およびTMB基質で検出した. 被検血清とスタンダードHpの示す吸光度を比較して患者がHp欠損か否かを判定した.結果: 上記の方法で, 血清中に存在する3μg/dL以上の濃度のHpを検出できた. また, ピークレートネフェロメトリー法で血清Hp含量が5mg/dL以下と測定された患者の中から, 先天性のHp欠損者を検出することができた. 判定は肉眼でも可能であった.結論: 本法は, 操作が簡便で, 検出感度が高い. 本法を用いれば先天性Hp欠損者と二次的に血中Hp含量が減少した患者の鑑別が可能である. 頻回輸血を必要とする患者の輸血時のアナフィラキシー発生の予防や, 将来のHp欠損者のためのドナープールの作製に有用な方法と思われる.


  • A CASE OF TRANSFUSION REACTION ASSOCIATED WITH ANTI-IgA ANTIBODY

    by Yukiko Furuta, Naomi Higashi, Yoshihisa Watanabe, Kazumi Isa, Eiko Shimada, Kazuyo Ikeda


  • SUCCESSFUL CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN A CASE OF ACUTE MYELOID LEUKEMIA WITH IgA DEFICIENCY

    by Kazuhiro Nagai, Emi Matsuo, Junko Inoue, Minoru Fujii, Eiko Shimada, Shigeki Mitsunaga, Yoshihisa Watanabe, Takuya Fukushima, Yasushi Miyazaki, Yukiko Fukahori, et al.


  • Open Access

    Anti-IgA antibodies detected in patients with nonhemolytic transfusion reactions.

    by Eiko Shimada, Masako Hirano, Yoshiharu Suzuki, Minoko Takanashi, Kazunori Nakajima, Kenji Tadokoro, Takeo Juji

    We used an enzyme-liked immunosorbent assay (ELISA) using polyclonal IgA purified from pooled plasma as an antigen for the screening of anti-IgA antibodies in sera from patients with nonhemolytic transfusion reactions (NHTRs). Among 154 patients referred to our laboratory from April 1994 to January 1995, two were positive for anti-IgA IgG antibodies. Specificites of the anti-IgA antibodies were examined by immunoblotting. Anti-IgA2m(1) and anti-IgA1 were detected in one case each. Sera from both patients contained normal levels of total IgA. In one case, a 43-year-old woman with chronic myelogenous leukemia showed urticaria followed by wheezing dyspnea and fever one hour after the start of platelet concentrate (PC) transfusion. In the other case, a 45-year-old woman with aplastic anemia complained of itching, urticaria, facial edema and nausea immediately after the start of PC transfusion. No antibodies against HLA, platelet-specific antigens or irregular antibodies against red blood cell antigens were detected in either patients' sera collected before transfusion or in the transfused blood in these cases. These findings suggested that these NHTRs might have been caused by subclass and allotype-specific anti-IgA antibodies. These results show that ELISA and Western blotting are useful in the detection of anti-IgA antibodies responsible for NHTRs.